Michael Altaweel

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. ncbi request reprint Macular hole: improved understanding of pathogenesis, staging, and management based on optical coherence tomography
    Michael Altaweel
    Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, USA
    Semin Ophthalmol 18:58-66. 2003
  2. ncbi request reprint Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study
    Michael Ip
    Department of Ophthalmology and Visual Science, University of Wisconsin, Clinical Science Center, Madison, WI 53792, USA
    Semin Ophthalmol 18:67-73. 2003
  3. ncbi request reprint A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema
    Emmett T Cunningham
    Stanford University, USA
    Ophthalmology 112:1747-57. 2005
  4. ncbi request reprint Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals
    Anthony P Adamis
    Ophthalmology 113:23-8. 2006
  5. doi request reprint Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial
    Maureen G Maguire
    Department of Ophthalmology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104 3309, USA
    Ophthalmology 115:1468-73, 1473.e1-2. 2008

Collaborators

  • Michael Ip
  • Neil M Bessler
  • David J Wilson
  • Dennis M Robertson
  • David J Browning
  • Susan B Bressler
  • Rajiv Anand
  • Neil M Bressler
  • Anthony P Adamis
  • Emmett T Cunningham
  • Maureen G Maguire
  • David R Guyer
  • Mauro Goldbaum
  • Manju Patel
  • Steven R Leff
  • Linda Wagner
  • Peter Reed Pavan
  • David S Lehnhardt
  • Cullen Mike Jones
  • Monique N McRay
  • Sharon Decker
  • Denise Krolnik
  • Margaret J Ruszczyk
  • Jeremy Miller
  • Robert Chambers
  • Karen M Gehrs
  • Albert M Maguire
  • Stephanie A Schura
  • John M Pach
  • Rachel Falk
  • Paul Sternberg
  • Elena Marcos
  • Jeffrey H Stockfish
  • James Yuhr
  • Michael Tolentino
  • Jacqueline L Hursky
  • Norma Jimenez
  • Deborah Elkins
  • Nancy Soueidan
  • Gaurav Shah
  • Marian McVicker
  • Cheryl Hambrock
  • Tammy Hanner
  • Alan J Ruby
  • Cindy M Wright
  • Brian Kritchman
  • Scott E Bohnen
  • Donald Doherty
  • Ann Ervin
  • Andrew N Antoszyk
  • Jay A Rostvold
  • David Orth
  • Matthew MacCumber
  • Steve Carlton
  • Rhonda Bowyer
  • Jennifer Cavanagh
  • Bryan Barts
  • Thea Tantum
  • Sandy Efird
  • Steven A Wallace
  • Jon Dahl
  • Pauline Merrill
  • Bruce Keyser
  • Heather L Davis
  • Patrick Rice
  • Janet Nutting
  • Hank A Aguado
  • Tatyana Metelitsina
  • Susan Sherouse
  • Siru Adhikari
  • Molly Doherty
  • Heather Murphy
  • Michael L Klein
  • William Nyberg
  • Matt Raeber
  • Judy Brower
  • Ed Heffron
  • Patricia Streasick
  • Michele Sheehan
  • Kevan Curren
  • Michelle D West
  • Jeffrey W Berger
  • Elna Rapp
  • Katie Reichenberger
  • Alyson Pohlman
  • John Martin
  • Kevin Blinder
  • Travis A Meredith
  • Barbara McCarty
  • Linda Davis

Detail Information

Publications6

  1. ncbi request reprint Macular hole: improved understanding of pathogenesis, staging, and management based on optical coherence tomography
    Michael Altaweel
    Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, USA
    Semin Ophthalmol 18:58-66. 2003
    ..OCT is useful in differentiating simulating lesions and in allowing better counseling of patients regarding their disorder. Finally, OCT findings are prognostic of surgical success and can assist in evaluating the results of surgery...
  2. ncbi request reprint Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study
    Michael Ip
    Department of Ophthalmology and Visual Science, University of Wisconsin, Clinical Science Center, Madison, WI 53792, USA
    Semin Ophthalmol 18:67-73. 2003
    ..Optical coherence tomography demonstrated significant anatomic improvement in the majority of patients with macular edema due to CRVO treated with intravitreal injection of triamcinolone acetonide...
  3. ncbi request reprint A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema
    Emmett T Cunningham
    Stanford University, USA
    Ophthalmology 112:1747-57. 2005
    ..To evaluate the safety and efficacy of pegaptanib sodium injection (pegaptanib) in the treatment of diabetic macular edema (DME)...
  4. ncbi request reprint Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals
    Anthony P Adamis
    Ophthalmology 113:23-8. 2006
    ..To study effects of intravitreal pegaptanib (Macugen) on retinal neovascularization...
  5. doi request reprint Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial
    Maureen G Maguire
    Department of Ophthalmology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104 3309, USA
    Ophthalmology 115:1468-73, 1473.e1-2. 2008
    ..To describe the characteristics of incident choroidal neovascularization (CNV) in observed and treated eyes in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT)...